160 related articles for article (PubMed ID: 21461653)
1. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.
Theodoropoulos GE; Gazouli M; Vaiopoulou A; Leandrou M; Nikouli S; Vassou E; Kouraklis G; Nikiteas N
Int J Colorectal Dis; 2011 Sep; 26(9):1113-8. PubMed ID: 21538054
[TBL] [Abstract][Full Text] [Related]
3. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
[TBL] [Abstract][Full Text] [Related]
5. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
[TBL] [Abstract][Full Text] [Related]
8. Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer.
Kesarwani P; Mandal RK; Maheshwari R; Mittal RD
BJU Int; 2011 Feb; 107(3):471-6. PubMed ID: 20804486
[TBL] [Abstract][Full Text] [Related]
9. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.
Zhu J; Qin C; Wang M; Yan F; Ju X; Meng X; Ding Q; Li P; Yang J; Cao Q; Zhang Z; Yin C
Mol Carcinog; 2010 Sep; 49(9):810-7. PubMed ID: 20572163
[TBL] [Abstract][Full Text] [Related]
11. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
12. Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer.
Wu Z; Li Y; Li S; Zhu L; Li G; Yu Z; Zhao X; Ge J; Cui B; Dong X; Tian S; Hu F; Zhao Y
Med Oncol; 2013; 30(3):565. PubMed ID: 23715747
[TBL] [Abstract][Full Text] [Related]
13. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
14. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
15. Functional variants in cell death pathway genes and risk of pancreatic cancer.
Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
[TBL] [Abstract][Full Text] [Related]
16. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
17. Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.
Zhang CD; Li HT; Liu K; Lin ZD; Peng QL; Qin X; He M; Wu H; Mo ZN; Yang XL
Asian Pac J Cancer Prev; 2014; 15(18):7713-8. PubMed ID: 25292051
[TBL] [Abstract][Full Text] [Related]
18. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
[TBL] [Abstract][Full Text] [Related]
20. A six-nucleotide deletion polymorphism in the casp8 promoter is associated with reduced risk of esophageal and gastric cancers in Kashmir valley.
Malik MA; Zargar SA; Mittal B
Indian J Hum Genet; 2011 Sep; 17(3):152-6. PubMed ID: 22345985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
